RedHill Biopharma reported $1000K in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 28M 11M Dec/2024
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 620.58M 475.91M Mar/2026
Cronos Group USD 1.35B 350.25M Mar/2026
RedHill Biopharma USD 1000K 6M Mar/2026